Tianjin TEDA Biomedical Engineering Company Limited (8189.HK)

HKD 0.28

(0.0%)

Market Cap (In HKD)

520.98 Million

Revenue (In HKD)

397.99 Million

Net Income (In HKD)

-20.15 Million

Avg. Volume

180.87 Thousand

Currency
HKD
Country
Basic Materials
Open
-
Prev. Close
-
Day Range
-
Year Range
0.065-0.4
PE
-
EPS
-
Beta Value
0.414
ISIN
CNE1000004H7
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Basic Materials
Industry
Agricultural Inputs
CEO
Ms. Li Sun
Employee Count
-
Website
https://www.bioteda.com
Ipo Date
2002-06-18
Details
Tianjin TEDA Biomedical Engineering Company Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of biological compound fertilizer products in the People's Republic of China. The company operates in two segments, Biological Compound Fertilizers Products, and Elderly Care and Health Care Services. Its biological compound fertilizer products include active fertilizer, mixture with nitrogen, phosphorus, and potassium with various formula that are used for the facilitation of balanced growth of grains, fruits, and vegetables. The company is also involved in the provision of integrated elderly and health care; and elderly equipment leasing services, as well as consulting, advisory, and assessment services. In addition, it provides and licenses electroencephalography photography (EEG) diagnosis detection services; and conducts EEG detection and diagnosis technology services. Further, the company engages in the research, development, manufacture, and application of biomedical science and technology projects; regional soil resources conditioning and remediation business; and provision of soil environmental quality standards research services. Tianjin TEDA Biomedical Engineering Company Limited was incorporated in 2000 and is headquartered in Tianjin, the People's Republic of China.